This presentation reviewed current radiotherapy facilities in the United States and treatment modalities, including niche modalities. The expanding variety of modalities were discussed, and the rationale behind these proposals. The clinical aspects of new modalities, purchasing considerations, and emotional and strategic issues were also reviewed. Panelists defined an economic decision formula for new technology, and discussed how this impacts the stakeholders in radiotherapy.
Panelists included: Anthony M. Berson, M.D., Radiation Oncology, St. Vincent’s Comprehensive Cancer Center and Richard Emery, Vice President, Aptium Oncology, Inc.; Executive Director, Trinitas Comprehensive Cancer Center.
Related Insights
December 24, 2025
Health Care Law Today
Gender-Affirming Care: Multi‑State Lawsuit Challenges HHS Declaration
As previously discussed in Foley’s healthcarelawtoday, on December 18, 2025, the U.S. Department of Health & Human Services (HHS) held a press conference focused on what it defined as “sex rejection procedures” (SRPs), also known as gender-affirming care (GAC) for minors, and outlined next steps.
December 23, 2025
Energy Current
FERC Opens New Paths for Co-Located Loads in PJM: What Data Center and Power Generation Developers Need to Know
Key Takeaways FERC has ordered PJM to overhaul its tariff framework for co-located generation and large loads, finding existing rules…
December 23, 2025
Foley Viewpoints
The Rush to Exit: PE Firms Pick Up the Pace in 2025
Key Points: PE firms are moving to sell portfolio companies on an accelerated timeline in 2025 after years of much longer hold…